Straits Research, a leading market research and consulting firm, has published an in-depth analysis of the global over-the-counter (OTC) artificial tears market. Valued at USD 4,565 million in 2021, the market is forecasted to achieve a valuation of USD 6,797 million by 2030, registering a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030.
Market Definition OTC artificial tears are lubricating eye drops formulated to treat dryness and irritation caused by insufficient tear production. These products are widely used for conditions like dry eye syndrome and to provide moisture for contact lenses. Their easy accessibility without a prescription makes them an essential component of eye care.
Get a Full PDF Sample Copy of the Report @ https://straitsresearch.com/report/otc-artificial-tears-market/request-sample
Key Market Dynamics
Latest Market Trends:
Increased adoption of preservative-free artificial tears due to reduced risk of allergic reactions and irritation.
Growing integration of advanced delivery systems such as spray solutions and single-dose containers to enhance user convenience and hygiene.
Market Drivers:
Rising prevalence of dry eye syndrome, attributed to increased screen time and aging populations globally.
Growing awareness of OTC artificial tears as an effective first-line treatment for eye discomfort and dryness.
Market Opportunities:
Expansion into emerging markets with large, untapped patient populations and increasing healthcare awareness.
Innovation in formulation, such as glycerin-based and oil-emulsion artificial tears, to address a broader range of consumer needs.
Market Segmentation
By Product
Solution
Ointment
Emulsion
Gel
Spray Solution
Suspensions
By Container Type
Plastic Single Dose Container
Plastic Multi-Dose Container
Others
By Type
Cellulose Derived Tears
Glycerin Derived Tears
Oil-Based Emulsion Tears
Polyethylene Glycol
By Delivery Method
Eye Drops
Ointments
By Application
Dry Eyes Treatment
Contact Lenses Moisture
By Formulation
Preservative Based
Non-Preservative Based
By Distribution Channel
Hospital Pharmacies
Drug Store & Retail Pharmacies
Online Pharmacies
Access Detailed Segmentation @ https://straitsresearch.com/report/otc-artificial-tears-market/segmentation
Regional Insights North America leads the OTC artificial tears market, driven by high awareness, advanced healthcare infrastructure, and significant demand for eye care products. Meanwhile, Europe is set to emerge as the fastest-growing region, owing to increasing screen-related eye strain and rising healthcare expenditures.
Key Players in the OTC Artificial Tears Market
AbbVie, Inc.
Akorn, Inc.
Alcon
Bausch & Lomb
Johnson & Johnson
Ocusoft
Santen Pharmaceutical Co. Ltd
Similasan Corporation
Sun Pharmaceutical Industries Limited
Ursapharm Arzneimittel GmbH
For More Information or Query or Customization Before Buying, Visit @ https://straitsresearch.com/buy-now/otc-artificial-tears-market
Future Outlook The OTC artificial tears market is poised for significant growth, supported by rising consumer awareness, innovations in formulation, and increasing demand for convenient eye care solutions. Straits Research’s comprehensive report offers valuable insights for stakeholders, helping them make informed decisions and capitalize on emerging market opportunities.
Comments